Emergent BioSolutions (EBS) Tax Provisions (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Tax Provisions of $6.6 million for Q1 2026, down 73.28% year-over-year from $24.7 million in Q1 2025, and up 69.23% quarter-over-quarter from $3.9 million in Q4 2025.
Emergent BioSolutions (EBS) Tax Provisions (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Tax Provisions history runs 16 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 73.28% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $12.1 million (down 82.54% YoY), while the FY2025 annual figure was $30.2 million, down 36.69% from the prior year.
- Tax Provisions for Q1 2026 stood at $6.6 million, up from $3.9 million in the prior quarter.
- The five-year high for Tax Provisions was $27.6 million in Q3 2024, with the low at -$26.4 million in Q2 2022.
- The 5-year median for Tax Provisions is $5.6 million (2022), against an average of $6.6 million.
- The sharpest annual moves came in 2022 and 2023: Tax Provisions sank 1115.38% in 2022, then soared 25700.0% in 2023.
- Emergent BioSolutions' Tax Provisions stood at $5.6 million in 2022, then plunged by 189.29% to -$5.0 million in 2023, then soared by 174.0% to $3.7 million in 2024, then rose by 5.41% to $3.9 million in 2025, then jumped by 69.23% to $6.6 million in 2026.
- Business Quant data shows EBS's Tax Provisions at $6.6 million in Q1 2026, $3.9 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 13.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.90 Mn |
| Mar 31, 2026 | 6.60 Mn |
| Dec 31, 2025 | 3.90 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | -4.80 Mn |
| Mar 31, 2025 | 24.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 27.60 Mn |
| Jun 30, 2024 | 13.30 Mn |
| Mar 31, 2024 | 3.10 Mn |
| Dec 31, 2023 | -5.00 Mn |
| Sep 30, 2023 | -2.50 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 25.60 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 19.90 Mn |
| Jun 30, 2022 | -26.40 Mn |
| Mar 31, 2022 | -100,000.00 |
| Dec 31, 2021 | 78.40 Mn |
| Sep 30, 2021 | -12.80 Mn |